Canada Markets closed

AbbVie Shareholders Will Get No Vote on Purchase of Allergan

Josh Nathan-Kazis

AbbVie shareholders will have no say in the Allergan acquisition, which will reshape the biopharmaceutical company as it integrates the maker of Botox into its operations.